Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cleveland Biolabs Inc (NASDAQ:CBLI)

3.28
Delayed Data
As of Sep 22
 +0.05 / +1.55%
Today’s Change
1.22
Today|||52-Week Range
5.55
+130.99%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$37.0M

Company Description

Cleveland BioLabs, Inc. is an innovative biopharmaceutical company, with a focus on oncology and acute radiation syndrome drug development. It is engaged in the research, development and commercialization of products to treat cancer and counteract the toxic effects of radio and chemotherapies for oncology patients. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY.

Contact Information

Cleveland BioLabs, Inc.
73 High Street
Buffalo New York 14203
P:(716) 849-6810
Investor Relations:

Employees

Shareholders

Other institutional2.75%
Mutual fund holders1.83%
Individual stakeholders1.16%

Top Executives

Yakov KoganChief Executive Officer
Langdon L. MillerPresident & Chief Medical Officer
John SzydloChief Financial Officer & Secretary
Andrei V. GudkovChief Scientific Officer
Michelle C. RossSenior VP-Public Health & Government Affairs